Researchers develop blood-brain-barrier-permeable nanoparticles for Alzheimer's disease treatment [23-08-2022]
Alzheimer´s disease (AD) is a complex neurodegenerative disease that leads to insidious deterioration of brain functions. Current treatments for AD that focus on inhibition of amyloid beta (A?) aggregation failed to show effectiveness in people with AD symptoms.
Related News
A nanotransistor sensor that simultaneously measures electrical and mechanical activity in heart cells [24-08-2022]
Reliable, portable, fast graphene sensors for COVID-19 [13-07-2022]
Nanomedicine, Graphene
Macrophages Polarized to Kill Cancer Cells with Nanotechnology [11-07-2022]
Nanobiotechnology, Nanomedicine
Nanoparticle vaccine protects against a spectrum of COVID-19-causing variants and related viruses [05-07-2022]
Nanobiotechnology, Nanomedicine
Protein nanoparticle vaccine shows potential for broader, safe SARS-CoV-2 vaccines [26-05-2022]
Nanobiotechnology, Nanomedicine

© Phantoms Foundation 2022